RxDoctor Payments Data

John Powell, MD

Family Medicine · Lenoir, NCNPI 1578591988

Payments from drug & device makers

$1,222in general payments, 2019–2025

Across 91 payments — averaging $13.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$256
  • GSK$164
  • Johnson & Johnson$134
  • AstraZeneca$119
  • Sanofi-aventis U.S. LLC$109
  • Boehringer Ingelheim$87
  • plus $354 from 8 others

What the payments were for

  • Food & beverage$1,222100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,222 in reported general payments places this provider in the 70th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$42,959
Medicare patients
162
Services billed
666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide116$125,680
EliquisApixaban89$95,840
Soliqua 100-33Insulin Glargine/Lixisenatide83$81,049
JardianceEmpagliflozin72$76,531
TrulicityDulaglutide47$59,181
XareltoRivaroxaban54$47,375
FarxigaDapagliflozin Propanediol53$45,164
Tresiba Flextouch U-200Insulin Degludec27$38,266
MounjaroTirzepatide32$33,298
InvokanaCanagliflozin15$25,895
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$21,989
KerendiaFinerenone27$21,460
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$20,928
MyrbetriqMirabegron14$15,589
Bydureon BciseExenatide Microspheres13$10,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$256$125,680116 claims
PfizerEliquis$64$95,84089 claims
Lilly USA, LLCTrulicity, Mounjaro$69$92,47879 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$109$84,134102 claims
Boehringer IngelheimJardiance$87$76,53172 claims
Johnson & JohnsonXarelto, Invokana$134$73,27069 claims
AstraZenecaFarxiga, Symbicort$119$50,63874 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$164$47,27173 claims
Astellas Pharma US IncMyrbetriq$26$15,58914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Lenoir

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →